<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-374" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Fluorides and Fluorocarbons Toxicity</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hays</surname>
            <given-names>Hannah L.</given-names>
          </name>
          <aff>Ohio State University COM</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mathew</surname>
            <given-names>Dana</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Chapman</surname>
            <given-names>Jennifer</given-names>
          </name>
          <aff>Lahey Health Systems</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Hannah Hays declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Dana Mathew declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jennifer Chapman declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>17</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-374.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Fluorocarbons are fluorinated carbon chain polymers that are used in an assortment of household and commercial products as waterproofing agents, lubricants, sealants, and leather conditioners. These products have been implicated in sporadic outbreaks of respiratory illness characterized by dyspnea, cough, and chest pain. Though typically self-limited, more severe exposure may lead to respiratory failure, acute respiratory distress syndrome (ARDS), and even death. Studies investigating the mechanism of fluoropolymer-related respiratory illness in humans have been difficult to perform for the following reasons: chemical formulation of these products is proprietary, chemical formulations are intermittently reformulated, product labels and safety data sheets (SDS) may not report fluorocarbon presence if present only in small amounts. This activity reviews the etiology, presentation, evaluation, and management/prevention of fluoride/fluorocarbon toxicity, and reviews the role of the interprofessional team in evaluating, diagnosing, and managing the condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Review the basic pathophysiology and toxicokinetics of fluorocarbon exposure toxicity.</p></list-item><list-item><p>Identify the common presenting features of fluoride and fluorocarbon toxicity on an examination/evaluation.</p></list-item><list-item><p>Outline the treatment and management strategies available for patients with fluoride/fluorocarbon toxicity.</p></list-item><list-item><p>Summarize how an optimally functioning interprofessional team would coordinate care to enhance outcomes for patients suffering from fluorocarbon toxicity.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=374&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=374">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-374.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Fluorocarbons are fluorinated carbon chain polymers that are used in an assortment of household and commercial products as waterproofing agents, lubricants, sealants, and leather conditioners<xref ref-type="bibr" rid="article-374.r1">[1]</xref>.</p>
        <p>These products have been implicated in sporadic outbreaks of respiratory illness characterized by dyspnea, cough, and chest pain<xref ref-type="bibr" rid="article-374.r2">[2]</xref>.&#x000a0;&#x000a0;Though typically&#x000a0;self-limited,&#x000a0;more severe exposure&#x000a0;may lead to respiratory failure, acute respiratory distress syndrome (ARDS), and even death.&#x000a0; Studies investigating the mechanism of fluoropolymer-related respiratory illness in humans have been difficult to perform for the following reasons:&#x000a0; chemical formulation of these products is proprietary, chemical formulations are intermittently reformulated, product labels and safety data sheets (SDS) may not report fluorocarbon presence if present only in small amounts<xref ref-type="bibr" rid="article-374.r3">[3]</xref>.</p>
      </sec>
      <sec id="article-374.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Fluoropolymers, also called fluorocarbons or perfluorocarbons, can be found in a variety of household and commercial products.&#x000a0; They are most&#x000a0;commonly encountered&#x000a0;as components of&#x000a0;waterproofing agents. Other uses include lubricants, sealants, and leather conditioners. Fluoropolymers are defined by the International Union of Pure and Applied Chemistry (IUPAC) as molecules consisting solely of carbon and fluorine.&#x000a0;However, compounds&#x000a0;that contain molecules other than carbon and fluorine (described as&#x000a0;fluorocarbon derivatives) are&#x000a0;often referred to as fluoropolymers as well.</p>
      </sec>
      <sec id="article-374.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Fluoropolymer-related respiratory illness has become a public health concern due to multiple occurrences of large population exposure<xref ref-type="bibr" rid="article-374.r4">[4]</xref><xref ref-type="bibr" rid="article-374.r2">[2]</xref>. In some instances, hundreds of victims have suffered respiratory illness due to exposure to fluoropolymers. A seasonal trend is seen with fluoropolymer-related respiratory illness, with an increase in cases during winter months.</p>
        <p>The onset of symptoms is rapid, within minutes to hours of exposure<xref ref-type="bibr" rid="article-374.r3">[3]</xref>.&#x000a0; The primary product handler is typically most affected. However, symptoms have been&#x000a0;known to develop&#x000a0;in patients with&#x000a0;only second-hand exposure.</p>
      </sec>
      <sec id="article-374.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Fluoropolymers are ultrafine particles ranging in size from 0.02-0.2 &#x000b5;m<xref ref-type="bibr" rid="article-374.r5">[5]</xref>.&#x000a0; These particles can aggregate and produce particle agglomerates measuring up to 15um<xref ref-type="bibr" rid="article-374.r6">[6]</xref><xref ref-type="bibr" rid="article-374.r7">[7]</xref>. This increased particle size is thought to occur with product aging and has been associated with attenuation of toxicity<xref ref-type="bibr" rid="article-374.r6">[6]</xref>.</p>
        <p>The compounds used in waterproofing products reportedly underwent a formulation change after the passage of Title IV of the Clean Air Act amendments and transitioned from a fluoroalkane structure to the more toxic fluoroalkene structure<xref ref-type="bibr" rid="article-374.r8">[8]</xref><xref ref-type="bibr" rid="article-374.r9">[9]</xref>. Due to their proprietary nature, specific information about the structures is not available to the public.&#x000a0;&#x000a0;Gas chromatography/mass spectroscopy (GC/MS) has been performed on some products to gain insight into the structural changes that has accompanied these reformulations<xref ref-type="bibr" rid="article-374.r8">[8]</xref>. Though these studies did not allow the identification of individual fluorocarbons, a change in composition from a fluoroalkane-containing product to one that contained fluoroalkenes was shown.</p>
        <p>Fluoroalkanes contain only single bonds and are more chemically stable and therefore of lower toxicity than fluoroalkenes, which contain double bonds<xref ref-type="bibr" rid="article-374.r10">[10]</xref><xref ref-type="bibr" rid="article-374.r11">[11]</xref>. Increasing numbers of carbon-fluorine bonds further increase the strength and stability of other nearby carbon-fluorine bonds; therefore, longer chain, saturated fluorocarbons, such as the fluoroalkanes, are the most chemically stable. Unsaturated structures, such as the fluoroalkenes, are much more reactive because the area of the double bond tends to be deficient in electrons, which makes them susceptible to attack by bases and other nucleophiles, such as fluorine and hydroxyl radicals<xref ref-type="bibr" rid="article-374.r10">[10]</xref><xref ref-type="bibr" rid="article-374.r12">[12]</xref>.</p>
        <p>Because these products have been associated with multiple occurrences of respiratory illness, with hundreds of victims involved in some outbreaks, fluoropolymer-related respiratory illness has become a public health concern. Despite this, a review of the literature on this topic fails to yield&#x000a0;a clearly elucidated&#x000a0;mechanism to explain why illness develops after exposure to some products and not others.</p>
        <p>The most convincing evidence to date regarding a mechanism of disease is the change in fluoropolymer structure (from fluoroalkane to fluoroalkene)<xref ref-type="bibr" rid="article-374.r3">[3]</xref>.&#x000a0;&#x000a0;It is theorized that this structural change&#x000a0;in conjunction with patient-specific factors (metabolic activation, smoking, preexisting medical conditions, etc.) is most likely to cause the development of illness. Other investigations have reported an association between the occurrence of outbreaks and changes in particle size, particle emission rate, and changes in the propellants or solvents. The presence of multiple different reformulations may explain the varying reports.</p>
      </sec>
      <sec id="article-374.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Fluoropolymer-related respiratory illness often resembles polymer fume fever, with acute respiratory signs and symptoms often accompanied by flu-like symptoms<xref ref-type="bibr" rid="article-374.r4">[4]</xref><xref ref-type="bibr" rid="article-374.r2">[2]</xref><xref ref-type="bibr" rid="article-374.r8">[8]</xref>. The most common symptoms are a non-productive cough and dyspnea<xref ref-type="bibr" rid="article-374.r13">[13]</xref>. A physical exam may reveal fever, tachycardia, increased work of breathing, wheezes, or rales.</p>
      </sec>
      <sec id="article-374.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Abnormal laboratory studies are often limited to those indicating inflammatory reactions, such as leukocytosis and elevated c-reactive protein (CRP)<xref ref-type="bibr" rid="article-374.r1">[1]</xref><xref ref-type="bibr" rid="article-374.r2">[2]</xref><xref ref-type="bibr" rid="article-374.r13">[13]</xref><xref ref-type="bibr" rid="article-374.r12">[12]</xref><xref ref-type="bibr" rid="article-374.r14">[14]</xref><xref ref-type="bibr" rid="article-374.r15">[15]</xref>.&#x000a0;Since fluoride is the most electronegative element, it binds tightly to cations such as calcium.&#x000a0; Due to calcium binding, fluorocarbon exposure could theoretically lead to hypocalcemia, similar to that seen following hydrofluoric acid exposures<xref ref-type="bibr" rid="article-374.r1">[1]</xref>. Despite this, there has been only one reported case&#x000a0;of hypocalcemia following fluorocarbon exposure, and this patient did not develop dysrhythmia or other untoward effects<xref ref-type="bibr" rid="article-374.r1">[1]</xref>.&#x000a0; Chest radiography may reveal infiltrates.</p>
      </sec>
      <sec id="article-374.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Basic supportive measures, such as removal of the exposure, fresh air, and supplemental oxygen, are adequate in many cases<xref ref-type="bibr" rid="article-374.r1">[1]</xref><xref ref-type="bibr" rid="article-374.r4">[4]</xref><xref ref-type="bibr" rid="article-374.r2">[2]</xref><xref ref-type="bibr" rid="article-374.r13">[13]</xref><xref ref-type="bibr" rid="article-374.r8">[8]</xref><xref ref-type="bibr" rid="article-374.r16">[16]</xref><xref ref-type="bibr" rid="article-374.r15">[15]</xref>. Inhaled beta-2 adrenergic agonists and corticosteroids have been used with success in patients with physical exam evidence of bronchospasm and may represent a reasonable intervention in selected cases<xref ref-type="bibr" rid="article-374.r15">[15]</xref><xref ref-type="bibr" rid="article-374.r16">[16]</xref><xref ref-type="bibr" rid="article-374.r17">[17]</xref><xref ref-type="bibr" rid="article-374.r2">[2]</xref><xref ref-type="bibr" rid="article-374.r4">[4]</xref>. Non-invasive positive pressure ventilation and endotracheal intubation have been required in some cases<xref ref-type="bibr" rid="article-374.r1">[1]</xref>. Treatment with antibiotics should be reserved for patients with clinical findings consistent with respiratory infection.</p>
      </sec>
      <sec id="article-374.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Arsenic toxicity</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Cardiac glycoside plant poisoning</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Chlorine toxicity</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Cough, Cold and Allergy preparation toxicity</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Disulfiram like mushroom toxicity</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Gyromitra mushroom toxicity</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Hallucinogenic mushroom toxicity</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Heavy metal toxicity</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Herb poisoning</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Hydrofluoric acid burns</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Liquorice poisoning</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Orellanine mushroom toxicity</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Scombroid toxicity</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Vitamin toxicity</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-374.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Most patients recover within 24 hours&#x000a0;<xref ref-type="bibr" rid="article-374.r18">[18]</xref><xref ref-type="bibr" rid="article-374.r1">[1]</xref><xref ref-type="bibr" rid="article-374.r4">[4]</xref>. In one study, approximately 50% of reported cases required hospital admission<xref ref-type="bibr" rid="article-374.r13">[13]</xref>.</p>
        <p>Pulmonary symptoms may last longer than other symptoms, such as nausea and fever.&#x000a0; In more severe cases, there have been reports of respiratory failure, acute respiratory distress syndrome, and rarely death<xref ref-type="bibr" rid="article-374.r3">[3]</xref>.</p>
      </sec>
      <sec id="article-374.s11" sec-type="Complications">
        <title>Complications</title>
        <p>While most patients experience a full recovery, chronic lung abnormalities and the development of pulmonary fibrosis have been reported<xref ref-type="bibr" rid="article-374.r8">[8]</xref>.&#x000a0;</p>
      </sec>
      <sec id="article-374.s12" sec-type="Consultations">
        <title>Consultations</title>
        <p>Poison centers have played a crucial role in the recognition of these disease outbreaks, with voluntary recalls beginning the first few days after the first reported illness in many cases and therefore, consultation with poison control is strongly recommended.</p>
      </sec>
      <sec id="article-374.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>General hygiene, such as the use of personal protective equipment, use in well-ventilated areas (outdoors if possible), frequent hand washing, and avoidance of smoking to avoid exposure to pyrolysis products, should be encouraged<xref ref-type="bibr" rid="article-374.r8">[8]</xref><xref ref-type="bibr" rid="article-374.r5">[5]</xref><xref ref-type="bibr" rid="article-374.r19">[19]</xref>. These products should be applied with a paintbrush when possible, as opposed to being volatilized by a spray apparatus<xref ref-type="bibr" rid="article-374.r8">[8]</xref><xref ref-type="bibr" rid="article-374.r5">[5]</xref>.</p>
      </sec>
      <sec id="article-374.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Patients should be educated about the association of these products with respiratory illness and reminded to use these products only as directed to help avoid future breakouts. Additionally, patients should be&#x000a0;made aware of the&#x000a0;fact that&#x000a0;many products&#x000a0;do not&#x000a0;list the presence of a fluorocarbon on the SDS&#x000a0;since it&#x000a0;comprises less than 1% of the total ingredients.&#x000a0;<xref ref-type="bibr" rid="article-374.r13">[13]</xref></p>
      </sec>
      <sec id="article-374.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=374&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=374">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/wilderness-and-environmental/fluorides-and-fluorocarbons-toxicity/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=374">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/374/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=374">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-374.s16">
        <title>References</title>
        <ref id="article-374.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bracco</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Favre</surname>
                <given-names>JB</given-names>
              </name>
            </person-group>
            <article-title>Pulmonary injury after ski wax inhalation exposure.</article-title>
            <source>Ann Emerg Med</source>
            <year>1998</year>
            <month>Nov</month>
            <volume>32</volume>
            <issue>5</issue>
            <fpage>616</fpage>
            <page-range>616-9</page-range>
            <pub-id pub-id-type="pmid">9795328</pub-id>
          </element-citation>
        </ref>
        <ref id="article-374.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <article-title>From the Centers for Disease Control and Prevention. Severe acute respiratory illness linked to use of shoe sprays--Colorado, November 1993.</article-title>
            <source>JAMA</source>
            <year>1993</year>
            <month>Dec</month>
            <day>22-29</day>
            <volume>270</volume>
            <issue>24</issue>
            <fpage>2915</fpage>
            <page-range>2915-6</page-range>
            <pub-id pub-id-type="pmid">8254842</pub-id>
          </element-citation>
        </ref>
        <ref id="article-374.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hays</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>Spiller</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Fluoropolymer-associated illness.</article-title>
            <source>Clin Toxicol (Phila)</source>
            <year>2014</year>
            <season>Sep-Oct</season>
            <volume>52</volume>
            <issue>8</issue>
            <fpage>848</fpage>
            <page-range>848-55</page-range>
            <pub-id pub-id-type="pmid">25200453</pub-id>
          </element-citation>
        </ref>
        <ref id="article-374.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <collab>Centers for Disease Control and Prevention (CDC)</collab>
            <article-title>Brief report: respiratory illness associated with boot sealant products--five states, 2005-2006.</article-title>
            <source>MMWR Morb Mortal Wkly Rep</source>
            <year>2006</year>
            <month>May</month>
            <day>05</day>
            <volume>55</volume>
            <issue>17</issue>
            <fpage>488</fpage>
            <page-range>488-90</page-range>
            <pub-id pub-id-type="pmid">16675946</pub-id>
          </element-citation>
        </ref>
        <ref id="article-374.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vernez</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Droz</surname>
                <given-names>PO</given-names>
              </name>
              <name>
                <surname>Lazor-Blanchet</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Jaques</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Characterizing emission and breathing-zone concentrations following exposure cases to fluororesin-based waterproofing spray mists.</article-title>
            <source>J Occup Environ Hyg</source>
            <year>2004</year>
            <month>Sep</month>
            <volume>1</volume>
            <issue>9</issue>
            <fpage>582</fpage>
            <page-range>582-92</page-range>
            <pub-id pub-id-type="pmid">15559330</pub-id>
          </element-citation>
        </ref>
        <ref id="article-374.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Warheit</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Seidel</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>Carakostas</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Hartsky</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Attenuation of perfluoropolymer fume pulmonary toxicity: effect of filters, combustion method, and aerosol age.</article-title>
            <source>Exp Mol Pathol</source>
            <year>1990</year>
            <month>Jun</month>
            <volume>52</volume>
            <issue>3</issue>
            <fpage>309</fpage>
            <page-range>309-29</page-range>
            <pub-id pub-id-type="pmid">2115007</pub-id>
          </element-citation>
        </ref>
        <ref id="article-374.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Seidel</surname>
                <given-names>WC</given-names>
              </name>
            </person-group>
            <article-title>Pulmonary response to perfluoropolymer fume and particles generated under various exposure conditions.</article-title>
            <source>Fundam Appl Toxicol</source>
            <year>1991</year>
            <month>Aug</month>
            <volume>17</volume>
            <issue>2</issue>
            <fpage>254</fpage>
            <page-range>254-69</page-range>
            <pub-id pub-id-type="pmid">1765219</pub-id>
          </element-citation>
        </ref>
        <ref id="article-374.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lazor-Blanchet</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Rusca</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Vernez</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Berry</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Albrecht</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Droz</surname>
                <given-names>PO</given-names>
              </name>
              <name>
                <surname>Boillat</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Acute pulmonary toxicity following occupational exposure to a floor stain protector in the building industry in Switzerland.</article-title>
            <source>Int Arch Occup Environ Health</source>
            <year>2004</year>
            <month>May</month>
            <volume>77</volume>
            <issue>4</issue>
            <fpage>244</fpage>
            <page-range>244-8</page-range>
            <pub-id pub-id-type="pmid">15007653</pub-id>
          </element-citation>
        </ref>
        <ref id="article-374.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hubbs</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Castranova</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Frazer</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Siegel</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Ducatman</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Grote</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schwegler-Berry</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Robinson</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Van Dyke</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Barger</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Xiang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Parker</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Acute lung injury induced by a commercial leather conditioner.</article-title>
            <source>Toxicol Appl Pharmacol</source>
            <year>1997</year>
            <month>Mar</month>
            <volume>143</volume>
            <issue>1</issue>
            <fpage>37</fpage>
            <page-range>37-46</page-range>
            <pub-id pub-id-type="pmid">9073590</pub-id>
          </element-citation>
        </ref>
        <ref id="article-374.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Clayton</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Toxicology of the fluoroalkenes: review and research needs.</article-title>
            <source>Environ Health Perspect</source>
            <year>1977</year>
            <month>Dec</month>
            <volume>21</volume>
            <fpage>255</fpage>
            <page-range>255-67</page-range>
            <pub-id pub-id-type="pmid">612451</pub-id>
          </element-citation>
        </ref>
        <ref id="article-374.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brown</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Rice</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Electron microscopy of rat lung following a single acute exposure to perfluoroisobutylene (PFIB). A sequential study of the first 24 hours following exposure.</article-title>
            <source>Int J Exp Pathol</source>
            <year>1991</year>
            <month>Aug</month>
            <volume>72</volume>
            <issue>4</issue>
            <fpage>437</fpage>
            <page-range>437-50</page-range>
            <pub-id pub-id-type="pmid">1883743</pub-id>
          </element-citation>
        </ref>
        <ref id="article-374.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Heinzer</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ribordy</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Kuzoe</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Lazor</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Fitting</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Recurrence of acute respiratory failure following use of waterproofing sprays.</article-title>
            <source>Thorax</source>
            <year>2004</year>
            <month>Jun</month>
            <volume>59</volume>
            <issue>6</issue>
            <fpage>541</fpage>
            <page-range>541-2</page-range>
            <pub-id pub-id-type="pmid">15170049</pub-id>
          </element-citation>
        </ref>
        <ref id="article-374.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Daubert</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Spiller</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Crouch</surname>
                <given-names>BI</given-names>
              </name>
              <name>
                <surname>Seifert</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Simone</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Smolinske</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Pulmonary toxicity following exposure to waterproofing grout sealer.</article-title>
            <source>J Med Toxicol</source>
            <year>2009</year>
            <month>Sep</month>
            <volume>5</volume>
            <issue>3</issue>
            <fpage>125</fpage>
            <page-range>125-9</page-range>
            <pub-id pub-id-type="pmid">19655284</pub-id>
          </element-citation>
        </ref>
        <ref id="article-374.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Woo</surname>
                <given-names>OF</given-names>
              </name>
              <name>
                <surname>Healey</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Sheppard</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Tong</surname>
                <given-names>TG</given-names>
              </name>
            </person-group>
            <article-title>Chest pain and hypoxemia from inhalation of a trichloroethane aerosol product.</article-title>
            <source>J Toxicol Clin Toxicol</source>
            <year>1983</year>
            <month>Jun</month>
            <volume>20</volume>
            <issue>4</issue>
            <fpage>333</fpage>
            <page-range>333-41</page-range>
            <pub-id pub-id-type="pmid">6689182</pub-id>
          </element-citation>
        </ref>
        <ref id="article-374.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wright</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Alveolitis after use of a leather impregnation spray.</article-title>
            <source>Br Med J (Clin Res Ed)</source>
            <year>1986</year>
            <month>Mar</month>
            <day>15</day>
            <volume>292</volume>
            <issue>6522</issue>
            <fpage>727</fpage>
            <page-range>727-8</page-range>
            <pub-id pub-id-type="pmid">3082413</pub-id>
          </element-citation>
        </ref>
        <ref id="article-374.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khalid</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Godfrey</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Ouellette</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <article-title>Chemical pneumonitis and subsequent reactive airways dysfunction syndrome after a single exposure to a household product: a case report.</article-title>
            <source>J Med Case Rep</source>
            <year>2009</year>
            <month>Nov</month>
            <day>09</day>
            <volume>3</volume>
            <fpage>112</fpage>
            <pub-id pub-id-type="pmid">19946590</pub-id>
          </element-citation>
        </ref>
        <ref id="article-374.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lalibert&#x000e9;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sanfa&#x000e7;on</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Blais</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Acute pulmonary toxicity linked to use of a leather protector.</article-title>
            <source>Ann Emerg Med</source>
            <year>1995</year>
            <month>Jun</month>
            <volume>25</volume>
            <issue>6</issue>
            <fpage>841</fpage>
            <page-range>841-4</page-range>
            <pub-id pub-id-type="pmid">7755212</pub-id>
          </element-citation>
        </ref>
        <ref id="article-374.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <collab>Centers for Disease Control and Prevention (CDC)</collab>
            <article-title>Severe acute respiratory illness linked to use of shoe sprays--Colorado, November 1993.</article-title>
            <source>MMWR Morb Mortal Wkly Rep</source>
            <year>1993</year>
            <month>Nov</month>
            <day>26</day>
            <volume>42</volume>
            <issue>46</issue>
            <fpage>885</fpage>
            <page-range>885-7</page-range>
            <pub-id pub-id-type="pmid">8232172</pub-id>
          </element-citation>
        </ref>
        <ref id="article-374.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vernez</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bruzzi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kupferschmidt</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>De-Batz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Droz</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lazor</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Acute respiratory syndrome after inhalation of waterproofing sprays: a posteriori exposure-response assessment in 102 cases.</article-title>
            <source>J Occup Environ Hyg</source>
            <year>2006</year>
            <month>May</month>
            <volume>3</volume>
            <issue>5</issue>
            <fpage>250</fpage>
            <page-range>250-61</page-range>
            <pub-id pub-id-type="pmid">16574608</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
